Screener
Relmada Therapeutics, Inc. RLMD Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Relmada Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055059
FAQ
- What is Relmada Therapeutics, Inc.'s price / book?
- Relmada Therapeutics, Inc. (RLMD) reported price / book of 3.3× in Q1 2026.
- How has Relmada Therapeutics, Inc.'s price / book changed year-over-year?
- Relmada Therapeutics, Inc.'s price / book increased by 735.7% year-over-year, from 0.4× to 3.3×.
- What is the long-term trend for Relmada Therapeutics, Inc.'s price / book?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s price / book has grown at a -13.4% compound annual growth rate (CAGR), from 8.4× to 4.1×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Relmada Therapeutics, Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude